A MK3.5 billion Chinese grant for maternal and newborn health in Malawi is set to reach three districts with strong coverage figures but weak underlying controls, as audit records show procurement failures, expired medicines and persistent supply-chain weaknesses across government.
By Collins Mtika
On 6 March 2026, officials gathered in Lilongwe to formalise the transfer of a MK3.5 billion Chinese grant aimed at reducing preventable maternal and newborn deaths in three Malawian districts.
The ceremony signalled a concrete commitment from a major bilateral partner.
It also marked the point at which a substantial sum entered one of the region’s most audited, and persistently troubled, public procurement environments.
That tension sits at the centre of this investigation. The grant, channelled through UNICEF and targeting Nkhata Bay, Balaka and Mwanza, is intended to reach about 200,000 people, including an estimated 50,000 pregnant women and 39,000 newborns over two years.
Health and Sanitation Minister Madalitso Baloyi cast the funding as a timely intervention, saying it would “significantly strengthen essential healthcare and service delivery for expectant mothers and newborns in our most vulnerable communities” and reinforce primary healthcare systems in the three targeted districts.
But the auditor general’s report for the year ended 31 March 2023, together with the programme’s own project draft, describes conditions that raise concrete questions about whether the investment will survive contact with the system it is entering.
In practical terms, routing the grant through UNICEF as a fiduciary buffer may reduce some risks at the point of transfer.
It does not resolve the deeper accountability failures auditors have repeatedly recorded inside the public health supply chain.
Past evidence, including medicines that expired in government warehouses, shows that funding commitments and effective delivery are not the same thing in this system.
Malawi has made measurable progress on maternal survival.
According to analyses cited in the project documents, the national maternal mortality ratio fell from about 675 deaths per 100,000 live births in 2010 to about 381 by 2020.

Neonatal mortality has also declined, from levels in the high 20s per 1,000 live births to below 20 in recent estimates. Both trends are real and documented.
Neither figure meets its Sustainable Development Goal target.
The SDG benchmark for maternal mortality is 70 deaths per 100,000 live births; for neonatal mortality, it is 12 per 1,000.
Malawi remains well above both thresholds, and the gap now appears to be driven less by access than by what happens inside facilities.
Baseline data for the 2023-24 financial year, cited in the project draft, show that skilled birth attendance exceeded 94 per cent across all three target districts. Most women in Nkhata Bay, Balaka and Mwanza are already delivering in health facilities.
That makes the persistence of maternal and neonatal deaths harder to explain, and easier to trace.
Countdown to 2030 reviews and related analyses cited in the draft repeatedly identify the quality of care inside facilities as the central failure point.
Problems documented include inadequate monitoring during labour, delayed clinical responses and persistent gaps in emergency obstetric and neonatal care, all of which are associated with preventable deaths.
The programme’s design reflects that diagnosis. It plans to upgrade maternity wards at 20 health facilities, support community health worker training across all three districts and strengthen referral systems, particularly in Nkhata Bay. In Balaka and Mwanza, the emphasis falls more heavily on primary-level services and outreach.
That intended delivery model is also central to UNICEF’s public case for the programme.
UNICEF Representative Dr Penelope Campbell said the partnership would deliver “critical, life-saving interventions directly to the communities that need them most” and, by combining health-facility services with community outreach, take “a pivotal step toward eliminating preventable deaths among mothers and babies in Malawi.”
The programme also places explicit emphasis on respectful maternity care, which national stakeholders and independent reviews have identified as a driver of avoidable delays in care-seeking.
The funding architecture was deliberately designed to introduce oversight. The money does not move directly from the Chinese government to the Malawi government. It flows through UNICEF, which the project draft describes as a fiduciary buffer.
The grant is also classified under Malawi’s Development Part 1 budget, a category for on-budget donor-funded projects intended to improve parliamentary visibility and traceability.
That structure matters. It reduces certain categories of financial risk. It does not, however, change the operational environment through which the money must pass before it reaches patients.
The Auditor General’s report for the year ended 31 March 2023 documented pervasive documentation failures across ministries, departments and agencies. In some cases, offices withheld records from auditors altogether. In others, payment vouchers lacked the required supporting documents.
The same report also cited what auditors described as a general flouting of procurement laws and regulations across government.
These are not isolated lapses. They describe systemic conditions affecting the same procurement units and district health offices through which medicines, equipment and supplies must move before reaching any of the 20 facilities the programme aims to upgrade.

The project draft itself points to a specific and documented precedent for failure at precisely this point. At the Central Medical Stores Trust, donated medicines reportedly expired in warehouses because of poor quantification and weak coordination with donors.
That outcome represents a complete breakdown of the supply chain: funds were committed, medicines were procured, and patients still did not receive them.
In a health system that the draft says remains heavily dependent on external financing for medicines and basic supplies, that failure is not a historical footnote. It is a warning about what can happen again.
The grant also enters a national budget under considerable strain. In Malawi’s 2024-25 budget, the health sector allocation, including water, sanitation and hygiene, rose to about MK723 billion from roughly MK330 billion the previous year.
The increase is real and measurable. It reflects a meaningful policy choice.
The proportional picture is less encouraging. The health sector’s projected share of the total budget stands at between 9 and 9.5 per cent, below the 15 per cent benchmark Malawi and other African governments committed to under the 2001 Abuja Declaration and slightly lower than the previous year’s share.
Analysts cited in the project documents indicate that debt service is consuming roughly a quarter of the national budget, squeezing the fiscal space available for health and other social sectors.
The structural consequence is that donor-funded programmes are carrying a disproportionate burden in areas where state capacity is already under documented pressure.
When procurement controls fail or supplies are diverted in that environment, the people who absorb the cost are those with the fewest alternatives – including pregnant women in the rural districts this programme is meant to serve.
Responsibility for programme performance is distributed across several identifiable institutions. The Ministry of Health retains overarching authority for health service delivery in the three target districts. UNICEF Malawi has a defined fiduciary role as both financial channel and implementing partner.
The Chinese government, as the bilateral donor, completed the formal transfer on 6 March 2026 in Lilongwe.
Malawi has amended its Public Procurement and Disposal of Assets Act to strengthen transparency around beneficial ownership and public contracts. Civil society groups and technical reviews cited in the project draft, however, say broader anti-leakage reforms remain incomplete.
Enforcement capacity in procurement units remains weak. Digital systems for tracking medicines and equipment through the supply chain are not yet fully operational.
What the public record now shows is a set of confident assurances from the programme’s principal actors. In the joint press statement issued at the handover, Baloyi, Ambassador Lu Xu and Campbell all stressed the grant’s expected benefits for mothers and newborns.
None of those published remarks, however, directly engaged with the auditor general’s findings on procurement breaches, missing records or previous supply-chain failures.
The public case for the programme is clear; the accountability case remains to be tested in implementation.
China has expanded its health-financing footprint across Eastern and Southern Africa, directing grants and concessional loans toward hospitals, laboratories and training programmes in multiple countries.
Ambassador Lu Xu framed the Malawi grant in strategic and humanitarian terms, saying: “By investing in maternal and newborn health, we are investing in the future of Malawi. This partnership reflects our shared vision of solidarity, development and the protection of the most vulnerable people.”
As that footprint grows, the question of how Chinese bilateral health grants interact with host-country procurement systems is becoming a more pressing concern for governments, auditors and civil society groups across the region.
The Malawi case tests a specific proposition: whether routing a bilateral grant through a multilateral fiduciary such as UNICEF provides enough protection against procurement and documentation failures already recorded in the underlying public system.
The answer will matter not only in Nkhata Bay, Balaka and Mwanza but also in comparable arrangements across sub-Saharan Africa where the same architecture is being applied.
The transfer ceremony in Lilongwe was the easiest part of what this programme must achieve. Skilled birth attendance above 94 per cent across all three target districts shows that geography and physical access are no longer the main barrier to survival for many women there.
The barrier is what happens after a woman reaches a facility. That depends on whether supplies are available, whether equipment works and whether the money invested can be fully accounted for at every stage of the supply chain.
The Auditor General’s 2023 report identified a system in which those basic conditions have often not held.
As the project draft itself suggests, the harder test is not the ceremony but whether women and newborns in the three districts see measurable gains: safer births, better-equipped facilities, stronger referral pathways and more respectful care.
That is where this programme will ultimately be judged.